Dewitt: Adrenal Flashcards
1
Q
Corticosteroids: Agonists and Antagonists
A
- Agonists:
- Glucocorticoids
- prednisode
- Mineralcorticoids
- fludrocortisone
- Glucocorticoids
- Antagnoists:
- Synthesis inhibitors:
- Ketoconazole
- Receptor Antagonists:
- Glucocorticoid antagonists:
- mifepristone
- Mineralocorticoid antagonists:
- apironolactone
- Glucocorticoid antagonists:
- Synthesis inhibitors:

2
Q
Adrenal Hormone Pathway
A
- Negative feedback: Androgens, glucocorticoids, mineralocorticoids

3
Q
What zone of the adrenal gland does mineralocorticoids, glucocorticoids, and androgens come from?
A
- Mineralocorticoids:
- zona glomerulosa (outer)
- Major: Aldosterone
- minor=deoxycorticosterone
- zona glomerulosa (outer)
- Glucocorticoids:
- zona fasciculata
- major=cortisol
- zona fasciculata
- Androgens
- Zona reticularis (inner)
4
Q
Clinical Presentation of Low mineralocorticoids
A
- Addison’s Disease=chronic adrenal insufficiency
- low aldosterone
- low blood pressure
- salt craving
- low aldosterone
5
Q
Pharmacological management of Low mineralocorticosteroid?
A
- cosyntropin/ACTH
- Fludrocortisone
6
Q
Cosyntropin
A
- Low mineralocorticoids or glucocorticoids
- diagnose if adrenal insufficiency is:
- primary-adrenal
- Secondary=pituitary
- Tertiary=Hypothalamus
7
Q
Fludorocortisone
A
- Low mineralocorticosteroid (Addison’s Disease)
- Synthetic corticosteroid
- Mechanism=cortisol Agonist (w/salt retaining activity)
- most widely used mineralocorticoid
- Long duration of action
- potent corticosteroid
- High salt-retaining activity
- Glucocorticoid activity
- low doses-no anti-inflammatory or anti-growth effects
8
Q
Desoxycorticosterone acetate
A
- Salt retaining agent w/no anti-inflammatory
- Not in US
9
Q
Clinical Presentaiton of High mineralocorticoids
A
- Cushing Syndrome or Primary Aldosteronism
- adrenal hypersecretion
- High aldosterone
- hypertension/edema
- adrenal hypersecretion
10
Q
Pharmacological management of High Mineralocorticoids?
A
- Aldosterone Antagonist
- Spironolactone
- Eplerenone
- Drospirenone
11
Q
Spironolactone
A
- High Mineralocorticoids (aldosterone)
- Aldosterone antagonist:
- does not reduce aldosterone production
- also:
- androgen antagonist
- progesterone agonist
- used to tx primary aldosteronism or higher doses to diagnose aldosteronism
- Side effects:
- breast tenderness
- irregular menstrual cycles
- impotence
- decreased libido
- gynecomastia in men
12
Q
Eplerenone
A
- Aldosterone Antagonist
- more selective than spironolactone
- Not a androgen antagonist
13
Q
Drospirenone
A
- Progestin
- Aldosterone antagonist
14
Q
Pharmacological management of low glucocorticoids
A
- Hydrocortisone
- may need fludrocortisone depending on degree of adrenal insufficiency
15
Q
Hydrocortisone
A
- cortisol agonists
- most common glucocorticoid for low glucocorticoid
- some salt retaining activity
- but may need fludrocortisone depending on degree of adrenal insufficiency (in primary insufficiency)
- Given in large amounts (IV) for:
- acute adrenal insufficiency
- congenital adrenal hyperplasia
- (Fludrocortison given for low mineralocorticoid production)
16
Q
Dexamethasone
A
- Synthetic Cortisol
- Pregnancies at high risk for congenital adrenal hyperplasia
- protect fetus
17
Q
Pharmacological management of high glucocorticoids
A
- Synthesis inihibitors:
- Aminoglutethimide
- Ketoconazole
- Etomidate
- Metyrapone
- Mifepristone
- Mitotane
18
Q
Synthesis of glucocorticoids
A
- multistep rpcoess
- many adrenal hormones share common pathways/starting products
19
Q
Aminoglutethimide
A
- High Glucocorticoids
- Mechanism: Cortisol Synthesis Inhibitors
- Blocks conversion of Cholesterol to prenenolone
- reduces synthesis of all hormon active steroids
- Tx: Cushing’s Syndrome
20
Q
Ketoconazole
A
- Antifungal Agent
- Mechanism=Cortisol synthesis inhibitors
- inhibits cholesterol side chain cleavage
- Tx: Cushing’s Syndrome
- Side effect:
- hepatotoxicity
21
Q
Etomidate
A
- Mechanism: Cortisol Synthesis Inhibitors
- Inhibits adrenal steroidogenesis
- ONLY parenteral agent for Cushings Syndrome
22
Q
Metyrapone
A
- Mechanism: Cortisol Synthesis Inhibitors:
- Selective inhibitor of specific enzyme in cortisol synthesis pathway
- Tx: Cushing’s Syndrome
- No longer in US except on compassionate basis
23
Q
Mifepristone (RU-486)
A
- Mechanism: Cortisol Antagonist
- Glucocorticoid Antagonist
- can cause generalized glucocorticoid resistance
- Tx: Only inoperable ectopic ACTH secretion or adrenal carcinoma
- failed to respond to other agents
- Due to:
- long Half life
- Widespread receptor antagonism
24
Q
Mitotane
A
- Mechanism: Cytotoxic to adrenal cortex
- nonselective cytotoxic on adrenal cortex to reduce tumors
- Removed from US market
- available on compassinate basis